Parkinson’s disease mouse models in translational research

被引:0
|
作者
Paul M. A. Antony
Nico J. Diederich
Rudi Balling
机构
[1] University of Luxembourg,Luxembourg Centre for Systems Biomedicine (LCSB)
[2] Centre Hospitalier de Luxembourg,Department of Neuroscience
来源
Mammalian Genome | 2011年 / 22卷
关键词
Bacterial Artificial Chromosome; MPTP; Translational Research; Nigrostriatal Dopaminergic Neuron; Nonmotor Symptom;
D O I
暂无
中图分类号
学科分类号
摘要
Animal models with high predictive power are a prerequisite for translational research. The closer the similarity of a model to Parkinson’s disease (PD), the higher is the predictive value for clinical trials. An ideal PD model should present behavioral signs and pathology that resemble the human disease. The increasing understanding of PD stratification and etiology, however, complicates the choice of adequate animal models for preclinical studies. An ultimate mouse model, relevant to address all PD-related questions, is yet to be developed. However, many of the existing models are useful in answering specific questions. An appropriate model should be chosen after considering both the context of the research and the model properties. This review addresses the validity, strengths, and limitations of current PD mouse models for translational research.
引用
收藏
页码:401 / 419
页数:18
相关论文
共 50 条
  • [31] Mouse models of Parkinson's disease associated with mitochondrial dysfunction
    Pickrell, Alicia M.
    Pinto, Milena
    Moraes, Carlos T.
    MOLECULAR AND CELLULAR NEUROSCIENCE, 2013, 55 : 87 - 94
  • [32] ‘Rejuvenation’ protects neurons in mouse models of Parkinson’s disease
    C. Savio Chan
    Jaime N. Guzman
    Ema Ilijic
    Jeff N. Mercer
    Caroline Rick
    Tatiana Tkatch
    Gloria E. Meredith
    D. James Surmeier
    Nature, 2007, 447 : 1081 - 1086
  • [33] Rodent models for gait network disorders in Parkinson's disease - a translational perspective
    Wenger, Nikolaus
    Vogt, Arend
    Skrobot, Matej
    Garulli, Elisa L.
    Kabaoglu, Burce
    Salchow-Hoemmen, Christina
    Schauer, Thomas
    Kroneberg, Daniel
    Schuhmann, Michael K.
    Harms, Christoph
    Endres, Matthias
    Isaias, Ioannis U.
    Tovote, Philip
    Blum, Robert
    Ip, Chi Wang
    EXPERIMENTAL NEUROLOGY, 2022, 352
  • [34] Animal Models of Parkinson's Disease: New models provide greater translational and predictive value
    Gamber, Kevin M.
    BIOTECHNIQUES, 2016, 61 (04) : 210 - 211
  • [36] Disease-modification in Translational Models of Parkinson's disease by the Rho Kinase Inhibitor Fasudil
    Toenges, L.
    Tatenhorst, L.
    Koch, J.
    Outeiro, T.
    Zweckstetter, M.
    Baehr, M.
    Lingor, P.
    MOVEMENT DISORDERS, 2017, 32
  • [37] MPTP Mouse Model of Preclinical and Clinical Parkinson's Disease as an Instrument for Translational Medicine
    Mingazov, Eduard R.
    Khakimova, Gulnara R.
    Kozina, Elena A.
    Medvedev, Alexei E.
    Buneeva, Olga A.
    Bazyan, Ara S.
    Ugrumov, Michael V.
    MOLECULAR NEUROBIOLOGY, 2018, 55 (04) : 2991 - 3006
  • [38] MPTP Mouse Model of Preclinical and Clinical Parkinson’s Disease as an Instrument for Translational Medicine
    Eduard R. Mingazov
    Gulnara R. Khakimova
    Elena A. Kozina
    Alexei E. Medvedev
    Olga A. Buneeva
    Ara S. Bazyan
    Michael V. Ugrumov
    Molecular Neurobiology, 2018, 55 : 2991 - 3006
  • [39] Translational methods to detect asymmetries in temporal and spatial walking metrics in parkinsonian mouse models and human subjects with Parkinson's disease
    Broom, Lauren
    Worley, Audrey
    Gao, Fay
    Hernandez, Laura D.
    Ashton, Christine E.
    Shih, Ludy C.
    VanderHorst, Veronique G.
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [40] Translational methods to detect asymmetries in temporal and spatial walking metrics in parkinsonian mouse models and human subjects with Parkinson’s disease
    Lauren Broom
    Audrey Worley
    Fay Gao
    Laura D. Hernandez
    Christine E. Ashton
    Ludy C. Shih
    Veronique G. VanderHorst
    Scientific Reports, 9